SABBY MANAGEMENT, LLC - Q2 2016 holdings

Add to watchlist

$1.92 Billion is the total value of SABBY MANAGEMENT, LLC's 287 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 57.9% .

All

			Value		Shares		↓ Weighting
	Sell	SPDR S&P 500put	$176,319,000	-6.5%	8,415	-17.3%	9.20%	-2.5%
	Sell	BIOGEN INCcall	$45,124,000	-74.0%	1,866	-72.0%	2.35%	-72.9%
	Sell	JOHNSON & JOHNSONcall	$34,073,000	-50.6%	2,809	-55.9%	1.78%	-48.5%
	Sell	MEDICINES COcall	$12,154,000	-59.7%	3,614	-62.0%	0.63%	-58.0%
	Sell	SPDR S&P 500 BIOTECHput	$10,050,000	-63.5%	1,858	-65.2%	0.52%	-62.0%
	Sell	RETROPHIN INCput	$8,595,000	+0.7%	4,826	-22.8%	0.45%	+4.9%
TENX	Sell	TENAX THERAPEUTICS INC	$6,671,000	+17.4%	2,606,035	-6.0%	0.35%	+22.5%
TKAI	Sell	TOKAI PHARMACEUTICALS	$4,128,000	-9.4%	749,205	-7.8%	0.22%	-5.7%
ABUS	Sell	ARBUTUS BIOPHARMA CORP	$4,093,000	-17.2%	1,176,031	-1.8%	0.21%	-13.4%
EIGR	Sell	EIGER BIOPHARMACEUTICALS INC	$3,473,000	-20.2%	175,249	-32.5%	0.18%	-17.0%
	Sell	REGULUS THERAPEUTIC INCcall	$3,341,000	-58.8%	11,560	-1.2%	0.17%	-57.1%
LBIO	Sell	LION BIOTECHNOLOGIES INC	$2,975,000	+42.1%	367,242	-10.9%	0.16%	+47.6%
NVLS	Sell	NIVALIS THERAPEUTICS INC	$2,951,000	+6.9%	641,492	-3.1%	0.15%	+11.6%
ITCI	Sell	INTRA CELLULAR THERAPIES INC	$2,793,000	+28.8%	71,943	-7.8%	0.15%	+35.2%
VXZ	Sell	BARCLAYS BANK IPATH S&P 500 MTetn	$2,805,000	-14.1%	260,000	-13.3%	0.15%	-10.4%
BIIB	Sell	BIOGEN INC	$2,418,000	-74.9%	10,000	-73.0%	0.13%	-73.9%
	Sell	BIOGEN INCput	$2,418,000	-91.2%	100	-90.5%	0.13%	-90.8%
RNN	Sell	REXAHN PHARMACEUTICALS INC	$2,279,000	-47.7%	9,071,168	-31.3%	0.12%	-45.4%
	Sell	CLOVIS ONCOLOGY INCcall	$2,231,000	-37.6%	1,626	-12.7%	0.12%	-35.2%
SAGE	Sell	SAGE THERAPEUTICS INC	$2,077,000	-35.2%	68,950	-31.0%	0.11%	-32.5%
ALQA	Sell	ALLIQUA BIOMEDICAL INC	$1,680,000	+4.2%	1,500,000	-23.7%	0.09%	+8.6%
	Sell	ACADIA PHARMACEUTICALS INCput	$1,607,000	-58.7%	495	-64.5%	0.08%	-56.9%
FOMX	Sell	FOAMIX PHARMACEUTICALS LTD	$1,611,000	-5.1%	253,706	-2.6%	0.08%	-1.2%
RDHL	Sell	REDHILL BIOPHARMA LTD	$1,611,000	-16.0%	147,500	-5.8%	0.08%	-12.5%
FGEN	Sell	FIBROGEN INC	$1,596,000	-31.3%	97,274	-10.8%	0.08%	-28.4%
MNTA	Sell	MOMENTA PHARMACEUTICALS INC	$1,572,000	-39.3%	145,600	-48.0%	0.08%	-36.9%
	Sell	DEPOMED INCcall	$1,546,000	-73.6%	788	-81.3%	0.08%	-72.4%
	Sell	REGENERON PHARMACEUTICALS INCcall	$1,502,000	-59.5%	43	-58.3%	0.08%	-58.1%
	Sell	ADURO BIOTECH INCcall	$1,495,000	-16.7%	1,322	-5.6%	0.08%	-13.3%
ADMS	Sell	ADAMAS PHARMACEUTICALS INC	$1,478,000	-48.9%	97,600	-51.2%	0.08%	-46.9%
SRNE	Sell	SORRENTO THERAPEUTICS INC	$1,421,000	-30.4%	253,805	-33.2%	0.07%	-27.5%
ORPN	Sell	BIO BLAST PHARMA LTD	$1,328,000	-53.0%	830,253	-26.8%	0.07%	-51.1%
RIBT	Sell	RICEBRAN TECHNOLOGIES INC	$1,304,000	+14.4%	785,476	-22.8%	0.07%	+19.3%
	Sell	AMICUS THERAPEUTICS INCput	$1,220,000	-58.6%	2,234	-35.9%	0.06%	-56.5%
XTLB	Sell	XTL BIOPHARMACEUTICALS LTDadr	$1,161,000	+8.2%	1,001,170	-3.8%	0.06%	+13.0%
BCLI	Sell	BRAINSTORM CELL THERAPEUTICS INC	$1,149,000	-12.8%	476,719	-3.3%	0.06%	-9.1%
CEMP	Sell	CEMPRA INC	$1,056,000	-39.7%	64,065	-35.9%	0.06%	-37.5%
ONCS	Sell	ONCOSEC MEDICAL INC	$997,000	-64.8%	608,052	-45.3%	0.05%	-63.4%
GALT	Sell	GALECTIN THERAPEUTICS INC	$974,000	-36.5%	662,467	-38.2%	0.05%	-33.8%
ACUR	Sell	ACURA PHARMACEUTICALS INC	$959,000	-47.8%	518,444	-20.1%	0.05%	-45.7%
AEZS	Sell	AETERNA ZENTARIS INC	$867,000	-47.0%	265,803	-46.0%	0.04%	-45.1%
DERM	Sell	DERMIRA INC	$781,000	-69.2%	26,693	-78.2%	0.04%	-67.7%
ITEK	Sell	INOTEK PHARMACEUTICALS CORP	$792,000	-8.1%	106,454	-8.6%	0.04%	-4.7%
	Sell	ACHILLION PHARMACEUTICALS INCput	$780,000	+0.5%	1,000	-0.5%	0.04%	+5.1%
ARLZ	Sell	ARALEZ PHARMACEUTICALS INC	$754,000	-10.1%	228,364	-3.4%	0.04%	-7.1%
PGNX	Sell	PROGENICS PHARMACEUTICALS INC	$738,000	-51.0%	174,900	-49.3%	0.04%	-48.0%
CAPR	Sell	CAPRICOR THERAPEUTICS INC	$719,000	+40.2%	182,083	-9.9%	0.04%	+46.2%
PSDV	Sell	PSIVIDA CORP	$730,000	-7.2%	257,800	-12.2%	0.04%	-2.6%
	Sell	GLOBAL BLOOD THERAPEUTICS INCcall	$698,000	-92.2%	421	-92.5%	0.04%	-91.9%
ABEO	Sell	ABEONA THERAPEUTICS ORD SHS	$637,000	-25.5%	270,000	-19.2%	0.03%	-23.3%
NUROW	Sell	NEUROMETRIX INC*w	$612,000	-51.1%	3,060,197	-2.2%	0.03%	-49.2%
MCRB	Sell	SERES THERAPEUTICS INC	$598,000	-67.5%	20,590	-70.3%	0.03%	-66.3%
CBMXW	Sell	COMBIMATRIX CORP.*w	$573,000	-6.1%	855,171	-6.1%	0.03%	-3.2%
CAPN	Sell	CAPNIA INC.	$581,000	-8.8%	501,240	-5.5%	0.03%	-6.2%
	Sell	ZAFGEN INCcall	$557,000	-42.3%	930	-35.7%	0.03%	-39.6%
PRQR	Sell	PROQR THERAPEUTICS N.V.	$532,000	-27.3%	110,000	-26.6%	0.03%	-24.3%
NWBO	Sell	NORTHWEST BIOTHERAPEUTICS INC	$512,000	-89.4%	881,585	-73.4%	0.03%	-88.8%
ATRS	Sell	ANTARES PHARMA INC	$445,000	-34.1%	424,100	-45.3%	0.02%	-32.4%
BNTC	Sell	BENITEC BIOPHARMA LTDadr	$438,000	-40.7%	345,576	-18.1%	0.02%	-37.8%
QRHC	Sell	QUEST RESOURCE HOLDING CORP	$382,000	-57.3%	1,315,708	-38.3%	0.02%	-55.6%
SCON	Sell	SUPERCONDUCTOR TECHNOLOGIES INC	$322,000	-38.4%	1,701,245	-37.8%	0.02%	-34.6%
NLNK	Sell	NEWLINK GENETICS CORP	$318,000	-86.3%	28,261	-77.8%	0.02%	-85.3%
CYNA	Sell	CYNAPSUS THERAPEUTICS INC	$305,000	-61.5%	18,194	-72.6%	0.02%	-60.0%
SKLN	Sell	SKYLINE MEDICAL INC	$298,000	-13.6%	1,957,037	-2.2%	0.02%	-5.9%
ANTH	Sell	ANTHERA PHARMACEUTICALS INC	$309,000	-57.1%	100,000	-49.7%	0.02%	-55.6%
AKTX	Sell	AKARI THERAPEUTICS PLCadr	$235,000	-61.2%	17,428	-57.2%	0.01%	-60.0%
CDTX	Sell	CIDARA THERAPEUTICS INC	$209,000	-59.2%	20,277	-49.7%	0.01%	-57.7%
	Sell	RELYPSA INCcall	$213,000	-66.8%	115	-75.7%	0.01%	-65.6%
LPCN	Sell	LIPOCINE INC	$194,000	-87.4%	63,875	-57.7%	0.01%	-87.0%
	Sell	RELYPSA INCput	$163,000	-71.0%	88	-78.8%	0.01%	-67.9%
	Sell	PROGENICS PHARMACEUTICALS INCcall	$152,000	-74.8%	361	-73.9%	0.01%	-73.3%
RGLS	Sell	REGULUS THERAPEUTIC INC	$142,000	-85.4%	49,231	-64.8%	0.01%	-85.7%
	Sell	ADVAXIS INCput	$113,000	-76.7%	140	-73.9%	0.01%	-75.0%
	Sell	NEWLINK GENETICS CORPput	$97,000	-76.9%	162	-29.9%	0.01%	-76.2%
ADHD	Sell	ALCOBRA LTD	$82,000	-89.2%	18,317	-90.9%	0.00%	-89.5%
	Sell	EDAP TMS S Aput	$52,000	-87.3%	157	-84.6%	0.00%	-85.0%
	Sell	INVIVO THERAPEUTICS HOLDINGS CORPcall	$58,000	-97.0%	100	-96.3%	0.00%	-96.8%
PVCT	Sell	PROVECTUS BIOPHARMACEUTICALS	$35,000	-87.3%	93,283	-87.2%	0.00%	-85.7%
BNTCW	Sell	BENITEC BIOPHARMA LTD*w	$24,000	-76.0%	98,146	-1.4%	0.00%	-80.0%
PRSNW	Exit	PERSEON EQUITY WARRANTS*w	$0	–	-1,887,892	-100.0%	0.00%	–
EYEGW	Sell	EYEGATE PHARMACEUTICALS INC*w	$2,000	-95.9%	53,893	-17.6%	0.00%	-100.0%
OPXAW	Exit	OPEXA THERAPEUTICS EQUITY WARRANTS*w	$0	–	-34,097	-100.0%	0.00%	–
RNVA	Exit	RENNOVA HEALTH INC	$0	–	-30,761	-100.0%	-0.00%	–
	Exit	ANTARES PHARMA INCcall	$0	–	-399	-100.0%	-0.00%	–
	Exit	BRAINSTORM CELL THERAPEUTICS INCcall	$0	–	-175	-100.0%	-0.00%	–
	Exit	CYTRX CORP INCcall	$0	–	-170	-100.0%	-0.00%	–
	Exit	TONIX PHARMACEUTICALS HOLDING CORPcall	$0	–	-148	-100.0%	-0.00%	–
	Exit	AVALANCHE BIOTECHNOLOGIES INCcall	$0	–	-106	-100.0%	-0.00%	–
	Exit	AKEBIA THERAPEUTICS INCcall	$0	–	-100	-100.0%	-0.01%	–
CBAY	Exit	CYMABAY THERAPEUTICS INC	$0	–	-67,534	-100.0%	-0.01%	–
BIOD	Exit	BIODEL INC	$0	–	-357,500	-100.0%	-0.01%	–
	Exit	TRILLIUM THERAPEUTICS INC	$0	–	-14,137	-100.0%	-0.01%	–
	Exit	NXSTAGE MEDICAL INCput	$0	–	-100	-100.0%	-0.01%	–
CERE	Exit	CERES INC.	$0	–	-720,378	-100.0%	-0.01%	–
	Exit	SYNERGY PHARMACEUTICALS EQUITY WARRANTS*w	$0	–	-285,414	-100.0%	-0.01%	–
ARQL	Exit	ARQULE INC	$0	–	-100,000	-100.0%	-0.01%	–
ALDX	Exit	ALDEYRA THERAPEUTICS INC	$0	–	-41,096	-100.0%	-0.01%	–
ARDX	Exit	ARDELYX INC	$0	–	-22,278	-100.0%	-0.01%	–
LPTN	Exit	LPATH INC	$0	–	-1,106,870	-100.0%	-0.01%	–
	Exit	TRANSENTERIX INCput	$0	–	-482	-100.0%	-0.01%	–
	Exit	HERON THERAPEUTICS INCcall	$0	–	-126	-100.0%	-0.01%	–
NSPH	Exit	NANOSPHERE ORD SHS	$0	–	-308,147	-100.0%	-0.01%	–
CLRB	Exit	CELLECTAR BIOSCIENCES INC	$0	–	-71,313	-100.0%	-0.01%	–
	Exit	THERAPEUTICSMD INCput	$0	–	-404	-100.0%	-0.01%	–
IONS	Exit	IONIS PHARMACEUTICALS INC	$0	–	-7,002	-100.0%	-0.01%	–
CMRX	Exit	CHIMERIX INC	$0	–	-53,620	-100.0%	-0.01%	–
	Exit	LIPOCINE INCcall	$0	–	-350	-100.0%	-0.02%	–
EBIO	Exit	ELEVEN BIOTHERAPEUTICS INC	$0	–	-1,213,984	-100.0%	-0.02%	–
THLD	Exit	THRESHOLD PHARMACEUTICALS INC	$0	–	-837,904	-100.0%	-0.02%	–
PSTI	Exit	PLURISTEM THERAPEUTICS INC	$0	–	-251,020	-100.0%	-0.02%	–
	Exit	EAGLE PHARMACEUTICALS INCput	$0	–	-100	-100.0%	-0.02%	–
	Exit	REGULUS THERAPEUTIC INCput	$0	–	-574	-100.0%	-0.02%	–
	Exit	SPECTRANETICS CORPcall	$0	–	-279	-100.0%	-0.02%	–
TROV	Exit	TROVAGENE INC	$0	–	-85,000	-100.0%	-0.02%	–
NSPR	Exit	INSPIREMD INC	$0	–	-790,538	-100.0%	-0.02%	–
EGRX	Exit	EAGLE PHARMACEUTICALS INC	$0	–	-10,000	-100.0%	-0.02%	–
	Exit	VALEANT PHARMACEUTICALS INTERNATIONAL INCcall	$0	–	-149	-100.0%	-0.02%	–
KOOL	Exit	CESCA THERAPEUTICS ORD SHS	$0	–	-111,094	-100.0%	-0.02%	–
SENS	Exit	SENSEONICS HOLDINGS INC	$0	–	-153,900	-100.0%	-0.02%	–
	Exit	GILEAD SCIENCES INCput	$0	–	-50	-100.0%	-0.02%	–
ALKS	Exit	ALKERMES PLC	$0	–	-15,000	-100.0%	-0.03%	–
BPMC	Exit	BLUEPRINT MEDICINES CORP	$0	–	-29,624	-100.0%	-0.03%	–
HALO	Exit	HALOZYME THERAPEUTICS INC	$0	–	-60,000	-100.0%	-0.03%	–
CYCC	Exit	CYCLACEL PHARMACEUTICALS INC	$0	–	-1,632,259	-100.0%	-0.03%	–
HTBX	Exit	HEAT BIOLOGICS INC	$0	–	-902,007	-100.0%	-0.03%	–
	Exit	OMEROS CORPcall	$0	–	-415	-100.0%	-0.03%	–
NTRA	Exit	NATERA INC	$0	–	-69,272	-100.0%	-0.03%	–
BLCM	Exit	BELLICUM PHARMACEUTICALS INC	$0	–	-77,020	-100.0%	-0.04%	–
OTIC	Exit	OTONOMY INC	$0	–	-50,000	-100.0%	-0.04%	–
	Exit	CYTOKINETICS INCcall	$0	–	-1,066	-100.0%	-0.04%	–
	Exit	ARIAD PHARMACEUTICALS INCcall	$0	–	-1,265	-100.0%	-0.04%	–
TBRA	Exit	TOBIRA THERAPEUTICS INC	$0	–	-100,000	-100.0%	-0.04%	–
ACHN	Exit	ACHILLION PHARMACEUTICALS INC	$0	–	-105,648	-100.0%	-0.04%	–
SGMO	Exit	SANGAMO BIOSCIENCES INC	$0	–	-134,500	-100.0%	-0.04%	–
TXMD	Exit	THERAPEUTICSMD INC	$0	–	-130,400	-100.0%	-0.04%	–
	Exit	INTERCEPT PHARMACEUTICALS INCput	$0	–	-72	-100.0%	-0.05%	–
ONTY	Exit	ONCOTHYREON INC	$0	–	-739,004	-100.0%	-0.05%	–
DSCO	Exit	DISCOVERY LABORATORIES INC	$0	–	-566,352	-100.0%	-0.05%	–
	Exit	MANNKIND CORPcall	$0	–	-6,000	-100.0%	-0.05%	–
MSTX	Exit	MAST THERAPEUTICS INC	$0	–	-3,877,356	-100.0%	-0.05%	–
SGYPQ	Exit	SYNERGY PHARMACEUTICALS INC	$0	–	-392,273	-100.0%	-0.05%	–
FLDM	Exit	FLUIDIGM INC	$0	–	-139,506	-100.0%	-0.06%	–
MDGNWS	Exit	MEDGENICS EQUITY WARRANTS EXP 13 FEB 2018*w	$0	–	-1,564,370	-100.0%	-0.06%	–
MRTX	Exit	MIRATI THERAPEUTICS INC	$0	–	-56,400	-100.0%	-0.06%	–
AKRXQ	Exit	AKORN INC	$0	–	-53,729	-100.0%	-0.06%	–
ACAD	Exit	ACADIA PHARMACEUTICALS INC	$0	–	-46,258	-100.0%	-0.06%	–
XLRN	Exit	ACCELERON PHARMA INC	$0	–	-50,000	-100.0%	-0.07%	–
AMRN	Exit	AMARIN CORP PLCadr	$0	–	-870,792	-100.0%	-0.07%	–
TTOO	Exit	T2 BIOSYSTEMS INC	$0	–	-145,000	-100.0%	-0.07%	–
NBIX	Exit	NEUROCRINE BIOSCIENCES INCcall	$0	–	-365	-100.0%	-0.07%	–
DEPO	Exit	DEPOMED INC	$0	–	-106,057	-100.0%	-0.07%	–
PRTA	Exit	PROTHENA CORP PLC	$0	–	-40,000	-100.0%	-0.08%	–
RLYP	Exit	RELYPSA INC	$0	–	-122,905	-100.0%	-0.08%	–
	Exit	BRISTOL-MYERS SQUIBB COcall	$0	–	-264	-100.0%	-0.08%	–
GWPH	Exit	GW PHARMACEUTICALS PLCads	$0	–	-24,603	-100.0%	-0.09%	–
CRDC	Exit	CARDICA INC	$0	–	-498,600	-100.0%	-0.09%	–
VRTX	Exit	VERTEX PHARMACEUTICALS INC	$0	–	-23,320	-100.0%	-0.09%	–
	Exit	MEDICINES CO 01JUN17 1.375%dbcv	$0	–	-1,500,000	-100.0%	-0.10%	–
	Exit	AKORN INCcall	$0	–	-815	-100.0%	-0.10%	–
OASMY	Exit	OASMIA PHARMACEUTICAL ABadr	$0	–	-477,836	-100.0%	-0.10%	–
RDUS	Exit	RADIUS HEALTH INC	$0	–	-65,000	-100.0%	-0.10%	–
	Exit	ADVAXIS INCcall	$0	–	-2,325	-100.0%	-0.10%	–
RTRX	Exit	RETROPHIN INC	$0	–	-156,774	-100.0%	-0.11%	–
DBVT	Exit	DBV TECHNOLOGIES S A	$0	–	-70,000	-100.0%	-0.11%	–
ANAC	Exit	ANACOR PHARMACEUTICALS INC	$0	–	-44,439	-100.0%	-0.12%	–
	Exit	TRANSENTERIX INCcall	$0	–	-5,916	-100.0%	-0.13%	–
	Exit	SYNERGY PHARMACEUTICALS INCcall	$0	–	-9,727	-100.0%	-0.13%	–
NBIX	Exit	NEUROCRINE BIOSCIENCES INC	$0	–	-70,000	-100.0%	-0.14%	–
AAVL	Exit	AVALANCHE BIOTECHNOLOGIES INC	$0	–	-540,632	-100.0%	-0.14%	–
	Exit	AKORN INCput	$0	–	-1,194	-100.0%	-0.14%	–
ESRX	Exit	EXPRESS SCRIPTS HOLDING CO	$0	–	-41,311	-100.0%	-0.14%	–
ALXN	Exit	ALEXION PHARMACEUTICALS INC	$0	–	-27,856	-100.0%	-0.19%	–
	Exit	EAGLE PHARMACEUTICALS INCcall	$0	–	-1,000	-100.0%	-0.20%	–
	Exit	ALEXION PHARMACEUTICALS INCput	$0	–	-342	-100.0%	-0.24%	–
	Exit	BLUEPRINT MEDICINES CORPcall	$0	–	-3,000	-100.0%	-0.27%	–
	Exit	BIOMARIN PHARMACEUTICAL 0.75%note	$0	–	-5,000,000	-100.0%	-0.29%	–
	Exit	ANACOR PHARMACEUTICALS INCcall	$0	–	-1,214	-100.0%	-0.32%	–
	Exit	GW PHARMACEUTICALS PLCput	$0	–	-908	-100.0%	-0.33%	–
	Exit	PORTOLA PHARMACEUTICALS INCcall	$0	–	-3,221	-100.0%	-0.33%	–
	Exit	LINKEDIN CORPcall	$0	–	-579	-100.0%	-0.33%	–
	Exit	EXPRESS SCRIPTS HOLDING COput	$0	–	-1,064	-100.0%	-0.37%	–
	Exit	UNITED THERAPEUTICS CORPcall	$0	–	-750	-100.0%	-0.42%	–
CYTX	Exit	CYTORI THERAPEUTICS INC	$0	–	-7,305,690	-100.0%	-0.72%	–
	Exit	EDWARDS LIFESCIENCES CORPput	$0	–	-2,201	-100.0%	-0.97%	–
	Exit	EDWARDS LIFESCIENCES CORPcall	$0	–	-2,477	-100.0%	-1.09%	–
	Exit	JOHNSON & JOHNSONput	$0	–	-2,061	-100.0%	-1.12%	–
SPY	Exit	SPDR S&P 500 ETF TRUSTunit	$0	–	-108,899	-100.0%	-1.12%	–
	Exit	GILEAD SCIENCES INCcall	$0	–	-8,440	-100.0%	-3.88%	–
	Exit	ISHARES RUSSELL 2000 ETFput	$0	–	-17,673	-100.0%	-8.12%	–
IMMU	Exit	IMMUNOMEDICS 15FEB20 4.75PCTnote	$0	–	-2,680,000	-100.0%	-9.12%	–

Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Mintz Hal #1

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR filed 2016-08-15

Signatures

The EDGAR filing(s) were signed by:

Robert Grundstein — Chief Operating Officer

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
SPDR S&P 500 ETF TRUST UNIT	40	Q2 2024	49.1%
ISHARES TR	38	Q2 2024	52.2%
SPDR S&P BIOTECHNOLOGY	32	Q3 2022	12.8%
AMARIN CORP PLC	30	Q4 2021	2.0%
BIOGEN INC	24	Q1 2021	26.2%
SAREPTA THERAPEUTICS INC	24	Q3 2020	4.6%
BIOGEN INC	23	Q1 2021	13.7%
SAREPTA THERAPEUTICS INC	22	Q3 2020	6.2%
BRAINSTORM CELL THERAPEUTICS INC	21	Q3 2023	1.6%
ISHARES TR	20	Q2 2024	12.7%

View SABBY MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)

SABBY MANAGEMENT, LLC Q2 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
Cyngn Inc.	January 04, 2024	5,322,048	10.0%
iBio, Inc.	January 04, 2024	200,303	10.0%
InMed Pharmaceuticals Inc.	January 04, 2024	524,972	10.0%
Phunware, Inc.	January 04, 2024	10,006,584	5.9%
TREASURE GLOBAL INC	January 04, 2024	5,338,587	10.0%
Arcadia Biosciences, Inc.	January 03, 2024	97,305	8.8%
Bluejay Diagnostics, Inc.	January 03, 2024	177,513	10.0%
Fangdd Network Group Ltd.	January 03, 2024	600,427	10.0%
GlucoTrack, Inc.	January 03, 2024	2,087,130	10.0%
LIPELLA PHARMACEUTICALS INC.	January 03, 2024	579,814	10.0%

View SABBY MANAGEMENT, LLC's complete significant-ownership history.

Latest filings

Type	Filed
N-PX	2024-09-04
4	2024-09-03
4	2024-08-30
4	2024-08-28
4	2024-08-26
4	2024-08-22
4	2024-08-20
4	2024-08-16
13F-HR	2024-08-14
4	2024-08-14

View SABBY MANAGEMENT, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export SABBY MANAGEMENT, LLC's holdings